Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease
Orlikowski D, Pellegrini N, Prigent H, Laforêt P, Carlier R, Carlier P, Eymard B, Lofaso F, Annane D.
Neuromuscul Disord. 2011. 21(7):477-82.
This open-label prospective exploratory study investigated the effect of 12 months of recombinant enzyme replacement therapy in 5 adult patients with severe Pompe disease.
Motor and respiratory function, quantitative muscle testing and spirometry were assessed. Concerning motor function assessed by MFM, 3 patients, wheelchair bound at baseline, improved sitting and proximal motor function and 2 patients improved in their ability to stand and transfer.
Alglucosidase alfa may stabilize or even slightly improve muscle strength and respiratory function among patients with severe Pompe disease.
Keywords: Pompe disease; Alglucosidase alfa; Enzyme replacement therapy; rhGAA
Articles dans les revues scientifiques
Activity rating scales in adult muscle disease: how well do they actually measure?
Seedat F, James MK, Rose MR. Muscle Nerve. 2014. 50(1):24-33. Systematic review to assess the quality of 19 activity rating scales, including the MFM, designed specifically for muscle disease.PubMed linkKeywords: Functional rating scales, Muscle disease, Outcome...
Activity rating scales in adult muscle disease: what do they actually measure?
Seedat F, James MK, Rose MR. Muscle Nerve. 2014. 50(1):14-23. Literature review of activity rating scales used for muscle disease and assessed their content by linking scale items to the International Classification of Functioning, Disability and Health (ICF) and the...
The Use of Functional Scales for Clinical Evaluation of Duchenne Muscular Dystrophy
Barra TMF, Baraldi KF Revista Neurociências. 2013. 21(3):420-426. Literature review of scientific articles, books and dissertations published from 2000 to 2011, in Portuguese, English and Spanish languages to demonstrate the applicability of using Vignos scales, Egen...
Assisted bicycle training delays functional deterioration in boys with duchenne muscular dystrophy: the randomized controlled trial “no use is disuse”.
Jansen M, van Alfen N, Geurts AC, de Groot IJ. Neurorehabil Neural Repair. 2013. 27(9):816-27. Thirty boys (18 ambulant and 12 wheelchair-dependent) with a DMD were physically trained using an assisted bicycle. After 24 weeks, the total MFM score remained stable in...
Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients.
Servais L, Deconinck N, Moraux A, Benali M, Canal A, Van Parys F, Vereecke W, Wittevrongel S, Mayer M, Desguerre I, Maincent K, Themar-Noel C, Quijano-Roy S, Serari N, Voit T, Hogrel JY. Neuromuscul Disord. 2013. 23(2) : 139-48. Development of new tools to precisely...
Motor Function Measure: validation of a short form (MFM-20) for young children with neuromuscular diseases
Capucine de Lattre, Christine Payan, Carole Vuillerot, Pascal Rippert, Denis de Castro, Carole Bérard, Isabelle Poirot and the MFM-20 Study Group. Arch Phys Med Rehabil. 2013. 94 : 2218-26. Validation of MFM version useful in neuromuscular children under 7 years old,...